In the News

413 News Items found
An MSK research notebook on a bench in a lab
MSK Research Highlights, August 10, 2023
New MSK research finds a potential target against neuroendocrine transformation in lung and prostate cancers; discovers new clues about why donor T cells attack certain tissues in graft-versus-host disease; sheds light on why T cells let go of their prey; and uses CRISPR interference and dynamic cell-state transitions to discover enhancers that affect early human development.
Pictured: American Association of Cancer Research Annual Meeting 2012
Announcement
The American Association for Cancer Research (AACR), the world's oldest and largest professional organization dedicated to advancing cancer research, held its 2012 annual meeting in Chicago.
Dr. Elli Papaemmanuil in her lab
Researchers have shown how CH, a blood condition related to aging, affects cancer outcomes — through a phenomenon called tumor-infiltrating clonal hematopoiesis.
Dr. Rona Yaeger
The targeted therapy adagrasib received accelerated approved for colorectal cancer caused by a mutation called KRAS-G12C, when used in combination with the drug cetuximab. MSK investigators have led much of the research that resulted in this combined drug approval.
Adrienne Boire at the lab bench
In the Lab
Research is providing new clues about how cancer spreads to spinal fluid, a condition called leptomeningeal metastasis.
Colored x-ray of lung cancer
In the Lab
Researchers are developing uses for a drug that could benefit many people with lung cancer.
Bob Li, MD, PhD, MPH
Memorial Sloan Kettering’s Bob Li served as principal investigator of the CodeBreaK 100 trial, the largest clinical trial conducted to date exclusively for patients with the KRAS G12C mutation.
Tumor mutation model
Finding
Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.
MSK scientist Britta Weigelt and MSK physician-scientist Sarah Kim
Learn how MSK’s liquid biopsy test, MSK-ACCESS, could improve the lives of patients with gynecologic cancers.
Illustration of cells with blue nuclei that have green DNA bits floating in the cytoplasm
In the Lab
Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.